Status:
RECRUITING
Assessment of Fatty Liver with Thermo-acoustic Device
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
ENDRA Life Sciences, Inc.
Conditions:
NASH
NAFLD
Eligibility:
All Genders
18-70 years
Brief Summary
The study will evaluate the accuracy of hepatic steatosis estimation by thermo-acoustic ultrasound with estimation by MRI-PDFF (Proton Density Fat Fraction) . It will also evaluate the sensitivity of ...
Detailed Description
Patients with either known or presumed diagnosis of non-alcoholic fatty liver disease who meets eligibility criteria will be included in the study. They will have imaging done to estimate hepatic stea...
Eligibility Criteria
Inclusion
- patients diagnosed or suspected to have non-alcoholic fatty liver disease
- Patients 18-70 years of age
- be able to understand and sign on written informed consent
- able to undergo ultrasound and MRI examinations
Exclusion
- any metal or electronic implants including but not limited to pacemakers, clips, hips
- known history of pregnancy or becoming pregnant during study period
- unable to understand and sign on written informed consent
- intolerant to ultrasound and/or MRI examinations
Key Trial Info
Start Date :
November 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04302051
Start Date
November 2 2023
End Date
December 31 2026
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert Hospital
Milwaukee, Wisconsin, United States, 53226